Eric Chen
Chinese-American entrepreneur (born 1998)
From Wikipedia, the free encyclopedia
Eric Chen (born August 28, 1998) is a Chinese-American entrepreneur and blockchain developer. He is the co-founder and chief executive officer of Injective Labs.[1]
Eric Chen | |
|---|---|
 | |
| Born | August 28, 1998 Shenzhen, China |
| Education | New York University |
| Occupations | Entrepreneur, blockchain developer |
| Known for | Co-founder and CEO of Injective Labs |
Biography
Chen was born in Shenzhen, China. He later moved to the United States, where he attended New York University (NYU), studying finance and computer science.[2] During his time at NYU, Chen became involved in blockchain technology, contributing to open-source projects and participating in blockchain-related academic initiatives.[3] From 2017 to 2018, Chen worked as a researcher at Innovating Capital, where his work included blockchain protocol research and trading strategies.[4]
In 2018, Chen co-founded Injective Labs with Albert Chon.[5] The company developed Injective Protocol, a blockchain platform designed for decentralized finance applications, including trading and derivatives.[6][7]
In March 2023, Chen announced the release of the inSVM rollup, the first Solana Sealvel Virtual Machine (SVM) rollup intended for the Solana developer community and Cosmos users.[8][9] In May, Eric Chen helped integrate Pyth with the Injective mainnet.[10][11]
Injective Protocol is built using the Cosmos SDK and supports various financial products such as spot and derivatives trading.[12][13][14]
In 2024, Forbes included Chen and Albert Chon in its 30 Under 30 Finance list as cofounders of Injective Labs.[15]
Chen has also spoken at a number of conferences, including ETHCC ETH Denver,[16] Avalanche Summit,[17] Binance Blockchain Week,[18] Permissionless, Messari Mainnet,[19]